Department of Biochemistry and Molecular Biology and UF-Shands Cancer Center, University of Florida, Gainesville, FL 32610, USA.
Carcinogenesis. 2011 Nov;32(11):1625-33. doi: 10.1093/carcin/bgr193. Epub 2011 Aug 26.
Aberrant activation of the Wnt/β-catenin signaling axis is a prominent oncogenic mechanism in numerous cancers including cervical cancer. Wnt inhibitory factor-1 (WIF1) is a secreted protein that binds Wnt and antagonizes Wnt activity. While the WIF1 gene is characterized as a target for epigenetic silencing in some tumor types, WIF1 expression has not been examined in human cervical tissue and cervical cancer. Here, we show that WIF1 is unmethylated and its gene product is expressed in normal cervical epithelium and some cultured cervical tumor lines. In contrast, several cervical cancer lines contained dense CpG methylation within the WIF1 gene, and expression of both WIF1 transcript and protein was restored by culturing cells in the presence of the global DNA demethylating agent 5-aza-2'-deoxycytidine. Using single-molecule MAPit methylation footprinting, we observed differences in chromatin structure within the WIF1 promoter region between cell lines that express and those that do not express WIF1, consistent with transcriptional activity and repression, respectively. The WIF1 promoter was aberrantly methylated in ∼60% (10 of 17) high-grade highly undifferentiated squamous cell cervical tumors examined, whereas paired normal tissue showed significantly lower levels of CpG methylation. WIF1 protein was not detectable by immunohistochemistry in tumors with quantitatively high levels of WIF1 methylation. Of note, WIF1 protein was not detectable in two of the seven unmethylated cervical tumors examined, suggesting other mechanisms may contribute WIF1 repression. Our findings establish the WIF1 gene as a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix.
Wnt/β-连环蛋白信号通路的异常激活是包括宫颈癌在内的许多癌症中的一个主要致癌机制。Wnt 抑制因子-1(WIF1)是一种分泌蛋白,可与 Wnt 结合并拮抗 Wnt 活性。虽然 WIF1 基因在某些肿瘤类型中被特征化为表观遗传沉默的靶标,但在人类宫颈组织和宫颈癌中尚未检测到 WIF1 表达。在这里,我们表明 WIF1 未甲基化,其基因产物在正常宫颈上皮和一些培养的宫颈肿瘤系中表达。相比之下,几种宫颈癌系在 WIF1 基因内含有密集的 CpG 甲基化,并且在存在全基因组去甲基化剂 5-氮杂-2'-脱氧胞苷的情况下培养细胞可恢复 WIF1 转录本和蛋白的表达。使用单分子 MAPit 甲基化足迹法,我们观察到在表达和不表达 WIF1 的细胞系之间,WIF1 启动子区域内的染色质结构存在差异,分别与转录活性和抑制一致。在检查的 17 个高级别高度未分化鳞状细胞宫颈癌中,约 60%(10/17)的 WIF1 启动子发生异常甲基化,而配对的正常组织显示出明显较低水平的 CpG 甲基化。在具有定量高 WIF1 甲基化水平的肿瘤中,通过免疫组织化学检测不到 WIF1 蛋白。值得注意的是,在检查的七个未甲基化宫颈癌中,有两个未检测到 WIF1 蛋白,这表明其他机制可能导致 WIF1 抑制。我们的研究结果确立了 WIF1 基因作为宫颈鳞状细胞癌中表观遗传沉默的一个常见靶标。